NCT05754567 CONCEPTT Kids International Neurodevelopmental Outcomes Among Offspring of Women With Type 1 Diabetes
| NCT ID | NCT05754567 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Manitoba |
| Condition | Neurocognitive Disorders |
| Study Type | OBSERVATIONAL |
| Enrollment | 225 participants |
| Start Date | 2023-09-07 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 225 participants in total. It began in 2023-09-07 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Neurodevelopmental Outcomes among Offspring of women with Type 1 Diabetes: A Follow up Study of the CONCEPTT Randomized Control Trial (CONCEPTT Kids International). An international, multicentre prospective cohort study of child and mother pairs. The potential number of recruits is 225 and the main inclusion criteria is child's mother who participated in the CONCEPTT Trial.
Eligibility Criteria
Inclusion Criteria: * Children of women who participated in the CONCEPTT trial at selected recruiting sites Exclusion Criteria: * NA
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05754567 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, studying Neurocognitive Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05754567 currently recruiting?
Yes, NCT05754567 is actively recruiting participants. Contact the research team at concepttkids@sunnybrook.ca for enrollment information.
Where is the NCT05754567 trial being conducted?
This trial is being conducted at Calgary, Canada, Halifax, Canada, Ottawa, Canada, Toronto, Canada and 6 additional locations.
Who is sponsoring the NCT05754567 clinical trial?
NCT05754567 is sponsored by University of Manitoba. The trial plans to enroll 225 participants.